Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11851/8351
Title: Turkish Ibd Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During Covid-19 Pandemic
Authors: Toruner, Murat
Kalkan, İsmail Hakkı
Akyüz, Filiz
Tezel, Ahmet
Çelik, Aykut Ferhat
Keywords: Inflammatory bowel diseases
Crohn's disease
ulcerative colitis
COVID-19 pandemic
Immune-Response
Opportunistic Infections
Clinical Characteristics
Vaccine
Therapy
Crohns
Risk
Publisher: Aves
Abstract: The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2, has resulted in high mortality and morbidity worldwide and is still a growing problem. Inflammatory bowel disease (IBD) is a chronic inflammatory disease for which a substantial number of patients are treated with immunosuppressive medications, either occasionally or long-term. Despite the accumulating evidence, there is still a lack of knowledge about the impact of COVID-19 on IBD patients, especially those who are under immunosuppressive treatment. Moreover, following the emergence of several COVID vaccines, there are concerns regarding vaccine effectiveness and possible side effects in such patients. In this context, we tried to briefly summarize the accumulating evidence and recommendations for the management of IBD in the context of the COVID-19 pandemic.
URI: https://doi.org/10.5152/tjg.2021.280721
https://hdl.handle.net/20.500.11851/8351
ISSN: 2148-5607
Appears in Collections:Dahili Tıp Bilimleri Bölümü / Department of Internal Medical Sciences
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

WEB OF SCIENCETM
Citations

2
checked on Dec 21, 2024

Page view(s)

166
checked on Dec 16, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.